Richard F. Pops
Director and CEO, Alkermes plc at Alkermes plc
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Neurocrine Biosciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alkermes plc May 20, 202698.6%
-
Alkermes plc May 21, 202597.2%
-
Neurocrine Biosciences Inc. May 21, 202585.1%
-
Alkermes plc May 31, 202495.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Neurocrine Biosciences Inc. | Option exercise | +3,318 | — | — |
| May 15, 2026 | Neurocrine Biosciences Inc. | Option exercise | +15,000 | $47.89 | $718,350 |
| May 15, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −15,000 | $157.65 | $2,364,750 |
| Feb 5, 2026 | Alkermes plc | Grant or award | +149,580 | — | — |
| Feb 5, 2026 | Alkermes plc | Shares withheld for tax | −62,230 | $33.55 | $2,087,817 |
| May 22, 2025 | Neurocrine Biosciences Inc. | Option exercise | +2,869 | — | — |
| Feb 6, 2025 | Alkermes plc | Grant or award | +190,640 | — | — |
| Feb 6, 2025 | Alkermes plc | Shares withheld for tax | −79,925 | $31.39 | $2,508,846 |
| May 17, 2024 | Neurocrine Biosciences Inc. | Option exercise | +4,199 | — | — |
| May 17, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −2,100 | $141.84 | $297,864 |
| Mar 13, 2024 | Neurocrine Biosciences Inc. | Option exercise | +23,200 | $42.76 | $992,032 |
| Mar 13, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −23,200 | $140.33 | $3,255,656 |
| Mar 11, 2024 | Neurocrine Biosciences Inc. | Option exercise | +100 | $42.76 | $4,276 |
| Mar 11, 2024 | Neurocrine Biosciences Inc. | Open-market sale | −100 | $140.00 | $14,000 |
| Mar 8, 2024 | Neurocrine Biosciences Inc. | Option exercise | +1,700 | $42.76 | $72,692 |
Questions about Richard F. Pops
What boards is Richard F. Pops on?
Richard F. Pops sits on the boards of Alkermes plc and Neurocrine Biosciences Inc.
What company is Richard F. Pops the CEO of?
Richard F. Pops is Director and CEO, Alkermes plc of Alkermes plc.
How long has Richard F. Pops served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.